A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

M. Purtscher,A. Trkola,G. Gruber,A. Buchacher,R. Predl,F. Steindl,C. Tauer,R. Berger,N. Barrett,A. Jungbauer,H. Katinger
DOI: https://doi.org/10.1089/AID.1994.10.1651
1994-12-01
AIDS Research and Human Retroviruses
Abstract:We have established a hybridoma clone, designated 2F5, secreting a neutralizing human monoclonal antibody (MAb) specific for gp41 of human immunodeficiency virus type 1 (HIV-1). The epitope of MAb 2F5 was mapped to amino acid sequence Glu-Leu-Asp-Lys-Trp-Ala on the ectodomain of gp41. In this study different in vitro test systems were used to characterize the neutralizing properties of MAb 2F5. In syncytium inhibition assays, fusion inhibition experiments, and neutralization assays on different HIV-susceptible cells (H9, U937, and peripheral blood mononuclear cells) MAb 2F5 showed broad-spectrum neutralizing capacity against HIV-1 laboratory isolates IIIB, MN, RF, and SF2. In addition, primary isolates from AIDS patients were also neutralized.
What problem does this paper attempt to address?